Importantly, treatment with tocilizumab in early onset T1D reduced the frequency of CXCR5hiPD-1hi Tfh cells confirming an essential role for the IL-6 pathway in human Tfh maintenance and biology. The gene discussed is IL6; the disease is type 1 diabetes mellitus.